Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs

Nanoparticulation of insoluble drugs improves dissolution rate, resulting in increased bioavailability that leads to increased stability, better efficacy, and reduced toxicity of drugs. Docetaxel (DTX), under the trade name Taxotere™, is one of the representative anticancer chemotherapeutic agents o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Choi, Jinhyang, Ko, Eunjung, Chung, Hye-Kyung, Lee, Jae Hee, Ju, Eun Jin, Lim, Hyun Kyung, Park, Intae, Kim, Kab-Sig, Lee, Joo-Hwan, Son, Woo-Chan, Lee, Jung Shin, Jung, Joohee, Jeong, Seong-Yun, Song, Si Yeol, Choi, Eun Kyung
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4598197/
https://ncbi.nlm.nih.gov/pubmed/26457052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S88375
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars